185 related articles for article (PubMed ID: 35069414)
1. Iron Deposition in Gray Matter Nuclei of Patients With Intracranial Artery Stenosis: A Quantitative Susceptibility Mapping Study.
Mao H; Dou W; Wang X; Chen K; Wang X; Guo Y; Zhang C
Front Neurol; 2021; 12():785822. PubMed ID: 35069414
[No Abstract] [Full Text] [Related]
2. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
[TBL] [Abstract][Full Text] [Related]
3. Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus.
Hu R; Gao B; Tian S; Liu Y; Jiang Y; Li W; Li Y; Song Q; Wang W; Miao Y
Front Neurosci; 2023; 17():1061156. PubMed ID: 36793541
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
[TBL] [Abstract][Full Text] [Related]
5. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension.
Qin Z; Wu W; Liu D; Zheng C; Kang J; Zhou H; Meng X; Haacke EM; Wang L
J Magn Reson Imaging; 2022 Aug; 56(2):508-515. PubMed ID: 34989062
[TBL] [Abstract][Full Text] [Related]
7. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.
Du L; Zhao Z; Cui A; Zhu Y; Zhang L; Liu J; Shi S; Fu C; Han X; Gao W; Song T; Xie L; Wang L; Sun S; Guo R; Ma G
ACS Chem Neurosci; 2018 Jul; 9(7):1849-1857. PubMed ID: 29722955
[TBL] [Abstract][Full Text] [Related]
8. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
[TBL] [Abstract][Full Text] [Related]
9. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
[TBL] [Abstract][Full Text] [Related]
10. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
[TBL] [Abstract][Full Text] [Related]
11. Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study.
Li Y; Sethi SK; Zhang C; Miao Y; Yerramsetty KK; Palutla VK; Gharabaghi S; Wang C; He N; Cheng J; Yan F; Haacke EM
Front Neurosci; 2020; 14():607705. PubMed ID: 33488350
[TBL] [Abstract][Full Text] [Related]
12. Quantitative susceptibility mapping to evaluate brain iron deposition and its correlation with physiological parameters in hypertensive patients.
Li X; Jin D; Zhu Y; Liu L; Qiao Y; Qian Y; Tian J; Jiang B; Hou C; Geng J; Li X; Gao X; Ma Y; Wang S; Zong J; Qin Y
Ann Transl Med; 2021 Oct; 9(20):1582. PubMed ID: 34790788
[TBL] [Abstract][Full Text] [Related]
13. Age and sex related differences in subcortical brain iron concentrations among healthy adults.
Persson N; Wu J; Zhang Q; Liu T; Shen J; Bao R; Ni M; Liu T; Wang Y; Spincemaille P
Neuroimage; 2015 Nov; 122():385-98. PubMed ID: 26216277
[TBL] [Abstract][Full Text] [Related]
14. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
[TBL] [Abstract][Full Text] [Related]
16. Different iron deposition patterns in hemodialysis patients with and without restless legs syndrome: a quantitative susceptibility mapping study.
Wang H; Han X; Jin M; Wang LY; Diao ZL; Guo W; Zhang P; Wang Z; Ding HY; Lv H; Zhang ZY; Zhao PF; Li J; Yang ZH; Liu WH; Wang ZC
Sleep Med; 2020 May; 69():34-40. PubMed ID: 32045852
[TBL] [Abstract][Full Text] [Related]
17. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
18. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
[TBL] [Abstract][Full Text] [Related]
19. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
[TBL] [Abstract][Full Text] [Related]
20. Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker.
Sun Y; Ge X; Han X; Cao W; Wang Y; Ding W; Cao M; Zhang Y; Xu Q; Zhou Y; Xu J
Front Aging Neurosci; 2017; 9():81. PubMed ID: 28424610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
